Literature DB >> 33513191

Temporally integrated single cell RNA sequencing analysis of PBMC from experimental and natural primary human DENV-1 infections.

Adam T Waickman1,2,3, Heather Friberg1, Gregory D Gromowski1, Wiriya Rutvisuttinunt1, Tao Li1, Hayden Siegfried1, Kaitlin Victor1, Michael K McCracken1, Stefan Fernandez4, Anon Srikiatkhachorn5,6, Damon Ellison1, Richard G Jarman1, Stephen J Thomas2, Alan L Rothman5, Timothy Endy3, Jeffrey R Currier1.   

Abstract

Dengue human infection studies present an opportunity to address many longstanding questions in the field of flavivirus biology. However, limited data are available on how the immunological and transcriptional response elicited by an attenuated challenge virus compares to that associated with a wild-type DENV infection. To determine the kinetic transcriptional signature associated with experimental primary DENV-1 infection and to assess how closely this profile correlates with the transcriptional signature accompanying natural primary DENV-1 infection, we utilized scRNAseq to analyze PBMC from individuals enrolled in a DENV-1 human challenge study and from individuals experiencing a natural primary DENV-1 infection. While both experimental and natural primary DENV-1 infection resulted in overlapping patterns of inflammatory gene upregulation, natural primary DENV-1 infection was accompanied with a more pronounced suppression in gene products associated with protein translation and mitochondrial function, principally in monocytes. This suggests that the immune response elicited by experimental and natural primary DENV infection are similar, but that natural primary DENV-1 infection has a more pronounced impact on basic cellular processes to induce a multi-layered anti-viral state.

Entities:  

Year:  2021        PMID: 33513191      PMCID: PMC7875406          DOI: 10.1371/journal.ppat.1009240

Source DB:  PubMed          Journal:  PLoS Pathog        ISSN: 1553-7366            Impact factor:   6.823


  42 in total

1.  Differing influences of virus burden and immune activation on disease severity in secondary dengue-3 virus infections.

Authors:  Daniel H Libraty; Timothy P Endy; Huo-Shu H Houng; Sharone Green; Siripen Kalayanarooj; Saroj Suntayakorn; Wanya Chansiriwongs; David W Vaughn; Ananda Nisalak; Francis A Ennis; Alan L Rothman
Journal:  J Infect Dis       Date:  2002-04-16       Impact factor: 5.226

2.  Molecular analysis of dengue virus attenuation after serial passage in primary dog kidney cells.

Authors:  B Puri; W M Nelson; E A Henchal; C H Hoke; K H Eckels; D R Dubois; K R Porter; C G Hayes
Journal:  J Gen Virol       Date:  1997-09       Impact factor: 3.891

3.  Risk factors in dengue shock syndrome.

Authors:  S Thein; M M Aung; T N Shwe; M Aye; A Zaw; K Aye; K M Aye; J Aaskov
Journal:  Am J Trop Med Hyg       Date:  1997-05       Impact factor: 2.345

4.  The live attenuated dengue vaccine TV003 elicits complete protection against dengue in a human challenge model.

Authors:  Beth D Kirkpatrick; Stephen S Whitehead; Kristen K Pierce; Cecilia M Tibery; Palmtama L Grier; Noreen A Hynes; Catherine J Larsson; Beulah P Sabundayo; Kawsar R Talaat; Anna Janiak; Marya P Carmolli; Catherine J Luke; Sean A Diehl; Anna P Durbin
Journal:  Sci Transl Med       Date:  2016-03-16       Impact factor: 17.956

5.  Dengue in the early febrile phase: viremia and antibody responses.

Authors:  D W Vaughn; S Green; S Kalayanarooj; B L Innis; S Nimmannitya; S Suntayakorn; A L Rothman; F A Ennis; A Nisalak
Journal:  J Infect Dis       Date:  1997-08       Impact factor: 5.226

6.  B cells are the principal circulating mononuclear cells infected by dengue virus.

Authors:  A D King; A Nisalak; S Kalayanrooj; K S Myint; K Pattanapanyasat; S Nimmannitya; B L Innis
Journal:  Southeast Asian J Trop Med Public Health       Date:  1999-12       Impact factor: 0.267

7.  A diverse range of gene products are effectors of the type I interferon antiviral response.

Authors:  John W Schoggins; Sam J Wilson; Maryline Panis; Mary Y Murphy; Christopher T Jones; Paul Bieniasz; Charles M Rice
Journal:  Nature       Date:  2011-04-10       Impact factor: 49.962

8.  Economic impact of dengue illness in the Americas.

Authors:  Donald S Shepard; Laurent Coudeville; Yara A Halasa; Betzana Zambrano; Gustavo H Dayan
Journal:  Am J Trop Med Hyg       Date:  2011-02       Impact factor: 2.345

Review 9.  Interferon-stimulated genes and their antiviral effector functions.

Authors:  John W Schoggins; Charles M Rice
Journal:  Curr Opin Virol       Date:  2011-12       Impact factor: 7.090

10.  Analysis of cell-associated DENV RNA by oligo(dT) primed 5' capture scRNAseq.

Authors:  Mark A Sanborn; Tao Li; Kaitlin Victor; Hayden Siegfried; Christian Fung; Alan L Rothman; Anon Srikiatkhachorn; Stefan Fernandez; Damon Ellison; Richard G Jarman; Heather Friberg; Irina Maljkovic Berry; Jeffrey R Currier; Adam T Waickman
Journal:  Sci Rep       Date:  2020-06-03       Impact factor: 4.379

View more
  2 in total

1.  Single-cell temporal analysis of natural dengue infection reveals skin-homing lymphocyte expansion one day before defervescence.

Authors:  Jantarika Kumar Arora; Anunya Opasawatchai; Tiraput Poonpanichakul; Natnicha Jiravejchakul; Waradon Sungnak; Oranart Matangkasombut; Sarah A Teichmann; Ponpan Matangkasombut; Varodom Charoensawan
Journal:  iScience       Date:  2022-03-05

2.  scATACpipe: A nextflow pipeline for comprehensive and reproducible analyses of single cell ATAC-seq data.

Authors:  Kai Hu; Haibo Liu; Nathan D Lawson; Lihua Julie Zhu
Journal:  Front Cell Dev Biol       Date:  2022-09-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.